Prognostic markers compared to CD3+TIL in locally advanced nasopharyngeal carcinoma

Nasser Al-Rajhi1, Shamayel F Mohammed2, Hatim A Khoja2

  • 1Department of Radiation Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Medicine
|November 19, 2021
PubMed

Related Concept Videos